← Catalyst calendarNBIX biotech catalysts & pipeline
NEUROCRINE BIOSCIENCES INC · Data as of 2026-09-08
Upcoming catalysts
direclidine — Topline data
2027
With multiple important clinical milestones in 2027, including Phase 3 readouts for osavampator in major depressive disorder and direclidine in schizophrenia, we are building an enduring company poised to deliver meaningful value for patients and shareholders for years to come.
Source filingosavampator — Topline data
2027
With multiple important clinical milestones in 2027, including Phase 3 readouts for osavampator in major depressive disorder and direclidine in schizophrenia, we are building an enduring company poised to deliver meaningful value for patients and shareholders for years to come.
Source filingExplore the free biotech catalyst calendar